MEDS: Rasio silihan jangka dawa marang modal trxadehealth.com

Lambang korporat lan logo TRxADE Health Corp (MEDS)

The asset value of TRxADE HEALTH, Inc. (MEDS) tracked on the GURU.Markets chart is 0.00, which correlates with the development of cloud B2B solutions and the implementation of AI in MedTech. Financial stability is based on support from online pharmacies and steady demand for medications. However, the business is currently undergoing a rigorous transformation due to displacement by major logistics players and a loss of position in digital distribution.

TRxADE (MEDS) - Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 30.10.2026
Produk asli TRxADE HEALTH Inc

To conduct high-quality stock selection, an investor must evaluate the stability of a company's financial leverage. This ratio compares liabilities with a maturity of over one year against the amount of equity. The asset-light model of TRxADE HEALTH (MEDS) featuring SaaS subscriptions minimizes the need for debt financing. This confirms the efficiency of a structure devoid of capital expenditures on logistics. An analysis of the long-term debt-to-equity ratio demonstrates high reliability and a conservative approach to debt.

Analisis perusahaan pesaing

Veeva Systems (VEEV) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas DOCS (Doximity Corp)|Rasio silihan jangka dawa marang modal HQY|Waystar Holding Corp. - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CRVL|PRVA - Utang jangka dawa marang ekuitas|Huron Consulting Group Inc. (HURN) - Rasio utang jangka dawa marang ekuitas|CERT: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Omnicell Health (OMCL)|GDRX (GoodRx Holdings, Inc.) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal SDGR (schrodinger.com)|Rasio utang jangka dawa marang ekuitas PHR (Phreesia)|Rasio silihan jangka dawa marang modal OMDA|Utang jangka dawa marang ekuitas Evolent EVH|Koefisien utang jangka dawa marang modal HSTM|DH: Rasio utang jangka dawa marang ekuitas|CCSI (consensus.com) - Rasio utang jangka dawa marang modal|AGL: Utang jangka dawa marang modal|Absci Corp (ABSI) - Utang jangka dawa marang modal|SY (SoYoung) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal NRC (nrchealth.com)|Utang jangka dawa marang modal SPOK|OPRX - Kewajiban jangka dawa marang modal|TruBridge - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal SLP|SOPHiA GENETICS S.A. - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal HCAT (Health Catalyst Inc)|CCLD: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal researchsolutions.com (RSSS)|DLHC (DLH Corp) - Utang jangka dawa marang modal|Utang jangka dawa marang modal OneMedNet Corp.|Utang jangka dawa marang ekuitas Scienture Holdings Inc. (SCNX)|Utang jangka dawa marang ekuitas HCTI (Healthcare Triangle Corporation)|iSpecimen - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal BFRG (Bullfrog AI Holdings, Inc.)|SCWorx - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal MSPR (MSP Recovery Inc.)|ICCT (icoreconnect.com) - Rasio utang jangka dawa marang ekuitas|Orgenesis Corporation - Koefisien utang jangka dawa marang modal|RCM (R1 RCM, Inc.) - Utang jangka dawa marang modal|sharecare.com (SHCR) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Streamline Health (STRM)|Syra Health Corp - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal AMEH (Apollo Medical Holdings, Inc.)|MODN - Rasio utang jangka dawa marang ekuitas|NXGN: Rasio utang jangka dawa marang ekuitas